Long B, Brady WJ, Koyfman A, et al. - In this brief report, researchers sought to describe cardiovascular complications in the setting of COVID-19 infection. Over one million people are infected worldwide and deaths of thousands of people are reported in correlation with the current COVID-19 pandemic. Less than 20% of patients with COVID-19 experience severe or critical illness. The virus binds and enters through angiotensin-converting enzyme 2 (ACE2). In patients with critical illness, complaints reported were pneumonia, ARDS, multiorgan dysfunction, and hemodynamic instability, as well as several cardiovascular complications including myocardial injury, myocarditis, acute myocardial infarction, heart failure, dysrhythmias, and venous thromboembolic events. Observations thereby indicate the correlation between COVID-19 and cardiac complications. Interaction of current therapies for COVID-19 with cardiovascular medications may occur. They recommend emergency clinicians be informed concerning these cardiovascular complications when evaluating and managing the patient with COVID-19.